Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S7.14
P/E—
Fwd P/E33.96
PEG2.84
52W— – —
RSI—
Target$403.93 (+19.7%)
Beta1.16
Div0.26%
Loading chart…
RSI (14)
Loading patterns…
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 44
Overbought · 100
Signal
Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
6Bullish
0Bearish
0Neutral
▲ Bull Flag — Breakout after +8% pole — bullish continuation
▲ Bull Flag — Breakout after +24% pole — bullish continuation
▲ Bull Flag — Breakout after +17% pole — bullish continuation
▲ Bull Flag — Breakout after +8% pole — bullish continuation
▲ Bull Flag — Breakout after +11% pole — bullish continuation
▲ Bull Flag — Breakout after +13% pole — bullish continuation
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
STRONG BUY
BuyHoldSell
Price Target Range
$403.93
+19.7% upside
Low $340
—
High $459
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | Outperform | — | ↔ Maintain | 2026-07-27 |
| BNP Paribas | Outperform | — | ● Initiate | 2026-07-13 |
| Morgan Stanley | Equal-Weight | — | ↔ Maintain | 2026-07-09 |
| Keybanc | Overweight | — | ↔ Maintain | 2026-07-02 |
| Barclays | Overweight | Equal-Weight → Overweight | ▲ Upgrade | 2026-06-09 |
| Stephens & Co. | Overweight | — | ↔ Reiterate | 2026-06-02 |
Evercore ISI Group
2026-07-27
Outperform
↔ Maintain
BNP Paribas
2026-07-13
Outperform
● Initiate
Morgan Stanley
2026-07-09
Equal-Weight
↔ Maintain
Keybanc
2026-07-02
Overweight
↔ Maintain
Barclays
2026-06-09
Overweight
(from Equal-Weight)
▲ Upgrade
Stephens & Co.
2026-06-02
Overweight
↔ Reiterate
Profitability
Gross Margin
36.79%TTM
Op. Margin
22.47%TTM
ROE
19.09%TTM
Rev. Growth
13.80%YoY
Free Cash Flow
277.94MTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
10.59MRQ
Current Ratio
2.82MRQ
Cash
435.80MMRQ
Total Debt
316.50MMRQ
Net Debt
—MRQ
Income
Div. Yield
0.26%TTM
Annual Rate
0.88Fwd
Payout Ratio
11.14%TTM
Dividend History
Payout Ratio (TTM): 11.14%
| Date | Amount / Share | Yield at Payment |
|---|---|---|
| 2026-07-29 | $0.2200 | 0.07% |
| 2026-04-29 | $0.2200 | 0.07% |
| 2026-01-28 | $0.2200 | 0.09% |
| 2025-11-12 | $0.2200 | 0.08% |
| 2025-07-30 | $0.2100 | 0.08% |
| 2025-04-30 | $0.2100 | 0.10% |
| 2025-02-07 | $0.2100 | 0.07% |
| 2024-11-13 | $0.2100 | 0.06% |
| 2024-07-31 | $0.2000 | 0.07% |
| 2024-04-23 | $0.2000 | 0.05% |
| 2024-01-30 | $0.2000 | 0.05% |
| 2023-11-07 | $0.2000 | 0.06% |
| 2023-07-25 | $0.1900 | 0.05% |
| 2023-04-25 | $0.1900 | 0.05% |
| 2023-01-24 | $0.1900 | 0.07% |
| 2022-11-08 | $0.1900 | 0.09% |
| 2022-07-19 | $0.1800 | 0.06% |
| 2022-04-19 | $0.1800 | 0.05% |
| 2022-01-18 | $0.1800 | 0.05% |
| 2021-11-09 | $0.1800 | 0.04% |
| 2021-07-20 | $0.1700 | 0.05% |
| 2021-04-20 | $0.1700 | 0.05% |
| 2021-01-19 | $0.1700 | 0.06% |
| 2020-11-09 | $0.1700 | 0.06% |
| 2020-07-28 | $0.1600 | 0.06% |
| 2020-04-21 | $0.1600 | 0.10% |
| 2020-01-21 | $0.1600 | 0.10% |
| 2019-10-22 | $0.1600 | 0.12% |
| 2019-07-23 | $0.1500 | 0.12% |
| 2019-04-16 | $0.1500 | 0.13% |
| 2019-01-22 | $0.1500 | 0.15% |
| 2018-10-23 | $0.1500 | 0.14% |
| 2018-07-17 | $0.1400 | 0.14% |
| 2018-04-17 | $0.1400 | 0.16% |
| 2018-01-17 | $0.1400 | 0.14% |
| 2017-10-17 | $0.1400 | 0.15% |
| 2017-07-17 | $0.1300 | 0.14% |
| 2017-04-17 | $0.1300 | 0.17% |
| 2017-01-13 | $0.1300 | 0.16% |
| 2016-10-17 | $0.1300 | 0.18% |
How WST Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 23.75B |
| Enterprise Value | 23.63B |
| Trailing P/E | 43.15 |
| Forward P/E | 33.96 |
| PEG Ratio (5yr) | 2.84 |
| Price/Sales (ttm) | 7.14 |
| Price/Book (mrq) | 8.00 |
| EV/Revenue | 7.10 |
| EV/EBITDA | 25.90 |
Share Statistics
| Avg Vol (3m) | 819.64K |
| Shares Outstanding | 70.38M |
| Float | 69.89M |
| % Held by Insiders | 0.64% |
| % Held by Institutions | 104.20% |
| Short Ratio | 2.90 |
| Short % of Float | 3.92% |
Profitability
| Gross Margin | 36.79% |
| Operating Margin (ttm) | 22.47% |
| Profit Margin | 16.98% |
| Return on Assets (ttm) | 11.38% |
| Return on Equity (ttm) | 19.09% |
Income Statement
| Revenue (ttm) | 3.33B |
| Revenue Growth (yoy) | 13.80% |
| Gross Profit (ttm) | 1.22B |
| EBITDA | 912.20M |
| Net Income (ttm) | 564.90M |
| Diluted EPS (ttm) | 7.82 |
| EPS Growth (yoy) | 18.10% |
Balance Sheet
| Total Cash (mrq) | 435.80M |
| Total Debt (mrq) | 316.50M |
| Debt / Equity (mrq) | 10.59 |
| Current Ratio (mrq) | 2.82 |
| Book Value / Share | 42.18 |
| Operating CF (ttm) | 662.20M |
| Free Cash Flow (ttm) | 277.94M |
Trading & Dividends
| Beta (5Y) | 1.16 |
| 50-Day MA | 336.74 |
| 200-Day MA | 284.11 |
| Fwd Dividend Yield | 26.00% |
| Payout Ratio | 11.14% |
Ownership Breakdown
Institutional 104.20%
Insider 0.64%
Short Interest
3.92% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in WST in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-12 | CAMPBELL SHANE ALDEN | Officer | 769 | — | |
| 2026-05-04 | HAUGEN JANET BRUTSCHEA | Director | Stock Award(Grant) at price 0.00 per share. | 791 | — |
| 2026-05-04 | LAI-GOLDMAN MYLA P | Director | Stock Award(Grant) at price 0.00 per share. | 791 | — |
| 2026-05-04 | FRIEL ROBERT F | Director | Stock Award(Grant) at price 0.00 per share. | 791 | — |
| 2026-05-04 | LOCKHART STEPHEN H | Director | Stock Award(Grant) at price 0.00 per share. | 791 | — |
| 2026-05-04 | KELLER DEBORAH L | Director | Stock Award(Grant) at price 0.00 per share. | 791 | — |
| 2026-05-04 | JOSEPH MOLLY E. | Director | Stock Award(Grant) at price 0.00 per share. | 791 | — |
| 2026-05-04 | MICHELS DOUGLAS A | Director | Stock Award(Grant) at price 0.00 per share. | 791 | — |
| 2026-05-04 | PUCCI PAOLO | Director | Stock Award(Grant) at price 0.00 per share. | 791 | — |
| 2026-05-04 | FEEHERY WILLIAM F. | Director | Stock Award(Grant) at price 0.00 per share. | 791 | — |
| 2026-05-04 | BUTHMAN MARK A | Director | Stock Award(Grant) at price 0.00 per share. | 791 | — |
| 2026-04-27 | FAVORITE ANNETTE F | Officer | Conversion of Exercise of derivative security at price 83.47 per share. | 2,817 | $235,135 |
| 2026-04-27 | WINTERS CHAD | Officer | Conversion of Exercise of derivative security at price 173.22 per share. | 896 | $155,205 |
| 2026-04-27 | WINTERS CHAD | Officer | Sale at price 300.67 per share. | 896 | $269,399 |
| 2026-04-27 | FAVORITE ANNETTE F | Officer | Sale at price 305.20 per share. | 2,817 | $859,753 |
| 2026-02-20 | WITHERSPOON CHARLES | Officer and Treasurer | 60 | — | |
| 2026-02-20 | WINTERS CHAD | Officer | 89 | — | |
| 2026-02-20 | POUSSOT RODOLPHE JEAN | Officer | 383 | — | |
| 2026-02-18 | FAVORITE ANNETTE F | Officer | 135 | — | |
| 2026-02-18 | GREEN ERIC MARK | Chief Executive Officer | 1,318 | — | |
| 2026-02-18 | POUSSOT RODOLPHE JEAN | Officer | 82 | — | |
| 2026-02-17 | WINTERS CHAD | Officer | Stock Award(Grant) at price 0.00 per share. | 149 | — |
| 2026-02-17 | FAVORITE ANNETTE F | Officer | Stock Award(Grant) at price 0.00 per share. | 441 | — |
| 2026-02-17 | WITHERSPOON CHARLES | Officer and Treasurer | Stock Award(Grant) at price 0.00 per share. | 115 | — |
| 2026-02-17 | GREEN ERIC MARK | Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 4,418 | — |
CAMPBELL SHANE ALDEN
Officer
2026-05-12
769 sh
—
HAUGEN JANET BRUTSCHEA
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-04
791 sh
—
LAI-GOLDMAN MYLA P
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-04
791 sh
—
FRIEL ROBERT F
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-04
791 sh
—
LOCKHART STEPHEN H
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-04
791 sh
—
KELLER DEBORAH L
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-04
791 sh
—
JOSEPH MOLLY E.
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-04
791 sh
—
MICHELS DOUGLAS A
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-04
791 sh
—
PUCCI PAOLO
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-04
791 sh
—
FEEHERY WILLIAM F.
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-04
791 sh
—
BUTHMAN MARK A
Director
Stock Award(Grant) at price 0.00 per share.
2026-05-04
791 sh
—
FAVORITE ANNETTE F
Officer
Conversion of Exercise of derivative security at price 83.47 per share.
2026-04-27
2,817 sh
$235,135
WINTERS CHAD
Officer
Conversion of Exercise of derivative security at price 173.22 per share.
2026-04-27
896 sh
$155,205
WINTERS CHAD
Officer
Sale at price 300.67 per share.
2026-04-27
896 sh
$269,399
FAVORITE ANNETTE F
Officer
Sale at price 305.20 per share.
2026-04-27
2,817 sh
$859,753
WITHERSPOON CHARLES
Officer and Treasurer
2026-02-20
60 sh
—
WINTERS CHAD
Officer
2026-02-20
89 sh
—
POUSSOT RODOLPHE JEAN
Officer
2026-02-20
383 sh
—
FAVORITE ANNETTE F
Officer
2026-02-18
135 sh
—
GREEN ERIC MARK
Chief Executive Officer
2026-02-18
1,318 sh
—
POUSSOT RODOLPHE JEAN
Officer
2026-02-18
82 sh
—
WINTERS CHAD
Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-17
149 sh
—
FAVORITE ANNETTE F
Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-17
441 sh
—
WITHERSPOON CHARLES
Officer and Treasurer
Stock Award(Grant) at price 0.00 per share.
2026-02-17
115 sh
—
GREEN ERIC MARK
Chief Executive Officer
Stock Award(Grant) at price 0.00 per share.
2026-02-17
4,418 sh
—